Mark E. Delaney
At a glance: Mark E. Delaney is Svp & Chief Commercial Officer at Quest Diagnostics (DGX). Their latest SEC Form 4, filed Jul 29, 2026, reported a sale of $376K. On file: 0 purchase lines ($0) and 2 sale lines ($1.9M).
Disclosed holdings: about $2.7M of DGX stock: 10,335 shares reported on their latest Form 4 (filed Jul 29, 2026), valued at the Nov 19, 2026 close of $259.06. This counts only DGX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Svp & Chief Commercial Officer at Quest Diagnostics Inc (DGX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Mark E. Delaney's InsiderPrint
2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 29SEC | DGXQuest Diagnostics Inc | Sell Plan | 1,60010,335 held (−13%) | $235.18 | $376K | +10.2% |
| Nov 20SEC | DGXQuest Diagnostics Inc | Sell Plan | 7,9467,530 held (−51%) | $187.35 | $1.5M | +38.3% |
- Sell
Svp & Chief Commercial Officer Mark E Delaney sold $376K of DGX at $235.18 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp & Chief Commercial Officer Mark E Delaney sold $1.5M of DGX at $187.35 — cuts the stake by 51%; pre-scheduled 10b5-1 plan sale.
Follow Mark E. Delaney
Get one email when Mark E. Delaney files a new purchase or sale. Free.
At most one email a day about Mark E. Delaney, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.